Leukemia in Down Syndrome: A Review

References

• Krivit W, Good R A. Simultaneous occurrence of mongolism and leukemia. Am J Dis Child. 1957; 94: 289–293
   PubMedGoogle Scholar
• Robison I X, Nesbit M E, Harland N. Down syndrome and acute leukemia in children: a 10-year retrospective survey from Children's Cancer Study Group. J Pediatr. 1984; 105: 235–242
   PubMed Web of Science ®Google Scholar
• Levitt G A, Stiller C A, Chessells J M. Prognosis of Down's syndrome with acute leukemia. Arch Dis Child. 1990; 65: 212–216
   PubMed Web of Science ®Google Scholar
• Kojima S, Matsuyama T, Sato T. Down's syndrome and acute leukemia in children: an analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction. Blood. 1990; 76: 2348–2353
   PubMed Web of Science ®Google Scholar
• Cairney E A, McKenna R, Arthur D C, Nesbit ME, Jr, Woods W J. Acute megakaryoblastic leukemia in children. Br J Haematol. 1986; 63: 541–554
   PubMed Web of Science ®Google Scholar
• Zipursky A, Peeters M, Poon A. Megakaryoblastic leukemia and Down's syndrome. Pediatr Hematol Oncol. 1987; 4: 211–230
   PubMed Web of Science ®Google Scholar
• Bevan D, Rose M, Greaves M. Leukemia of platelet precursors: diverse features in four cases. Br J Haematol. 1982; 51: 147–164
   PubMed Web of Science ®Google Scholar
• Breton-Gorius J, Villeval J L, Kieffer N. Limits of phenotypic markers for the diagnosis of megakaryoblastic leukemia. Blood Cells 1989; 15: 259–277
   PubMedGoogle Scholar
• Malkin D, Freedman M. Childhood erythroleukemia: review of clinical and biological features. Am J Pediatr Hematol Oncol. 1989; 11: 348–359
   PubMedGoogle Scholar
• Debili N, Kieffer N, Mitjavila M T. Expression of platelet glycoprotein by erythroid blasts in four cases of trisomy 21. Leukemia. 1989; 3: 669–678
   PubMed Web of Science ®Google Scholar
• Nishi T, Nakahata T, Koike K. Induction of mixed erythroid megakaryocyte colonies and bipo-tential blast cell colonies by recombinant human erythropoietin in serum-free culture. Blood. 1990; 76: 1330–1335
   PubMed Web of Science ®Google Scholar
• Coulombel L, Derycke M, Villeval J L. Characterization of the blast population in two neonates with Down's syndrome and transient myeloproliferative disorder. Br J Haematol. 1987; 66: 69–76
   PubMed Web of Science ®Google Scholar
• Cosson A, Despres P, Gazengel C. Unusual leukemic syndrome in newborn trisomy 21: megakaryocyte and platelet proliferation with diffuse intravascular coagulation. Nouv Rev Fr Hematol. 1974; 14: 181–198
   PubMedGoogle Scholar
• Eguchi M, Sakakibara H, Suda J. Ultrastructural and ultracytochemical differences between transient myeloproliferative disorder and megakaryoblastic leukemia in Down's syndrome. Br J Haematol. 1989; 73: 315–322
   PubMed Web of Science ®Google Scholar
• Homans A. Personal communication
   Google Scholar
• Becroft D MO, Zwi J. Perinatal visceral fibrosis accompanying the megakaryoblastic leukemoid reaction of Down syndrome. Pediatr Pathol 1990; 10: 397–406
   PubMedGoogle Scholar
• Zerres K, Schwanitz G, Niesen M. Prenatal diagnosis of acute non-lymphoblastic leukemia in Down syndrome. Lancet. 1990; 335: 117–118
   PubMedGoogle Scholar
• Iselius L, Jacobs P, Morton N. Leukaemia and transient leukaemia in Down syndrome. Hum Genet. 1990; 85: 477–485
   PubMed Web of Science ®Google Scholar
• Abe K, Kajii T, Niikawa N. Disomic homozygosity of 21-trisomic cells: a mechanism responsible for transient myeloproliferative syndrome. Hum Genet. 1989; 82: 313–316
   PubMed Web of Science ®Google Scholar
• Lorber B J, Freeman S, Hassold T. Characterization and molecular analysis of non-disjunction in 18 cases of trisomy 21 and leukemia. Genes Chroma Cancer 1992; 4: 1–7
   PubMedGoogle Scholar
• Antonarakis S E. Parental origin of the extra chromosome in trisomy 21 as indicated by analysis of DNA polymorphisms. N Engl J Med. 1991; 324: 872–876
   PubMed Web of Science ®Google Scholar
• Kuruhashi H, Junichi H, Keiko Y. Monoclonal nature of transient abnormal myelopoiesis in Down's syndrome. Blood. 1991; 77: 1161–1163
   PubMedGoogle Scholar
• Fialkow P J, Janssen J W, Bartram C R. Clonal remissions in acute non-lymphoblastic leukemia: evidence for a multistep pathogenesis of the malignancy. Blood. 1991; 77: 1415–1417
   PubMed Web of Science ®Google Scholar
• Fialkow P J, Martin P J, Najfeld V. Evidence for a multistep pathogenesis of chronic myelogenous leukemia. Blood. 1981; 58: 158–163
   PubMed Web of Science ®Google Scholar
• Quaglino D, Hayhoe F GJ. Periodic acid-Schiff positivity in erythroblasts with special reference to Di Guglielmo's syndrome. Br J Haematol. 1960; 6: 26–33
   PubMed Web of Science ®Google Scholar
• Suda J, Eguchi M, Ozawa T. Platelet peroxidase-positive blasts in transient myeloproliferative disorder with Down's syndrome. Br J Haematol. 1988; 68: 181–187
   PubMed Web of Science ®Google Scholar
• Suda T, Suda J, Miura Y. Clonal analysis of basophil differentiation in bone marrow cultures from a Down's syndrome patient with megakaryoblastic leukemia. Blood. 1985; 66: 1278–1283
   PubMed Web of Science ®Google Scholar
• Martin D IK, Zon L I, Mutter G. Expression of an erythroid transcription factor in megakaryocyte and mast cell lineages. Nature 1990; 344: 444–447
   PubMed Web of Science ®Google Scholar
• Weinberger M W, Oleinick A. Congenital marrow dysfunction in Down's syndrome. J Pediatr. 1970; 77: 273–270
   PubMed Web of Science ®Google Scholar
• Miller M, Cosgriff J M. Hematological abnormalities in newborn infants with Down syndrome. Am J Hum Genet. 1983; 16: 173–177
   Google Scholar
• Thüring W, Tönz O. Neqnatale thrombozytenwerte bei kindern mit Down-syndrome and anderen autosomalen trisomien. Helv Paediatr Acta. 1979; 34: 545–555
   PubMedGoogle Scholar
• Standen G, Philip M A, Fletcher J. Reduced number of peripheral blood granulocytic progenitor cells in patients with Down syndrome. Br J Haematol. 1979; 42: 417–423
   PubMedGoogle Scholar
• Mittwoch V. Frequency of drumsticks in normal women and in patients with chromosomal abnormalities. Nature 1964; 201: 317–319
   PubMed Web of Science ®Google Scholar
• Mellman W J, Oski F A, Tedesco T A. Leucocyte enzymes in Down's syndrome. Lancet. 1964; 2: 674–675
   PubMedGoogle Scholar
• Kretschmer R R, Lopez-Osuna M, De La Rosa L. Leukocyte function in Down's syndrome: quantitative NBT reduction and bactericidal capacity. Clin Immunol Immunopathol. 1974; 2: 449
   Google Scholar
• Ganick D J. Hematological changes in Down's syndrome. CRC Crit Rev Oncol/Hematol. 1986; 6: 55–69
   PubMedGoogle Scholar
• Miller R W. Down's syndrome (mongolism), other congenital malformations and cancers among the sibs of leukemic children. N Engl J Med. 1963; 268: 393–401
   Google Scholar
• Fraumeni J F, Jr., Manning W D, Mitus W J. Acute childhood leukemia: epidemiologic study by cell type of 1263 cases at the Children's Cancer Research Foundation in Boston. JNCI 1971; 46: 461–470
   PubMed Web of Science ®Google Scholar